Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility.
Our aims are to (1) set forth a multiprinciple system for selecting among clinical trials competing for limited space in an immunotherapy production facility that supplies products under investigation by scientific investigators; (2) defend this system by appealing to justice principles; and (3) ill...
| Publicado en: | American Journal of Bioethics Vol. 18; no. 4; pp. 58 - 68 |
|---|---|
| Autores principales: | , , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Taylor & Francis Ltd
Apr2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128907454&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 128907454 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15265161 FKZ jtl: American Journal of Bioethics issn: 15265161 maglogo: N pubinfo: dt: Apr2018 vid: 18 iid: 4 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 128907454 128907454 128907454 10.1080/15265161.2018.1444817 128907454 ppf: 58 ppct: 10 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility. aug: au: Jecker, Nancy S. Wightman, Aaron G. Rosenberg, Abby R. Diekema, Douglas S. affil: University of Washington sug: subj: Immunotherapy Clinical Trials Research Ethics Research, Medical Health Resource Allocation Occupational Justice ab: Our aims are to (1) set forth a multiprinciple system for selecting among clinical trials competing for limited space in an immunotherapy production facility that supplies products under investigation by scientific investigators; (2) defend this system by appealing to justice principles; and (3) illustrate our proposal by showing how it might be implemented. Our overarching aim is to assist manufacturers of immunotherapeutic products and other potentially breakthrough experimental therapies with the ethical task of prioritizing requests from scientific investigators when production capacity is limited. pubtype: Academic Journal doctype: tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|